Molecular Oncology, EarlyView.Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Influence of Direct Supervisors' Attitude on Depression among Nurses: Analysis of the Korean Working Conditions Survey. [PDF]
Iran J Public HealthPark S, Nam SH.
europepmc +1 more source
Working Conditions for Improving Pure Stretchability of Sheet Metals : The Effect of Punch Profile
, 1982 Masanori Kobayashi +2 more
openalex +2 more sources
Unfavourable working conditions for female GPs. A comparison between Swedish general practitioners and district nurses [PDF]
, 2002 Susan Wilhelmsson +3 more
openalex +1 more source
Olympic Sponsors Shamed by New Report on Working Conditions [PDF]
, 2008 International Labor Rights Forum
core +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
Molecular Oncology, EarlyView.In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
How the pandemic shaped presenteeism trends between healthcare and non-healthcare workers using the Korean working conditions surveys (2010-2023). [PDF]
Sci RepMin A, Ji Y, Baek W.
europepmc +1 more source
Effect of de-industrialisation on working conditions and self reported health in a sample of manufacturing workers [PDF]
, 2002 A. Ostry
openalex +1 more source
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source